Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
Clinical trial NCT04620187 · RECRUITING
Trial details
- NCT number
- NCT04620187
- Sponsor
- Dana-Farber Cancer Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-24
- Primary completion
- 2028-02-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.